CAITLIN STATON: Open Payments
NPI 1942956537 · DENHAM SPRINGS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,882 in 169 payments from 23 companies in 2025. Trend: 2023 $2,421 · 2024 $2,631 · 2025 $3,882
Food & beverage: $3,882
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $473 |
| Axsome Therapeutics, Inc. | 11 | $447 |
| ABBVIE INC. | 22 | $437 |
| PFIZER INC. | 16 | $313 |
| Amgen Inc. | 18 | $280 |
| Paratek Pharmaceuticals, Inc. | 14 | $280 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $274 |
| Novo Nordisk Inc | 10 | $255 |
| Lilly USA, LLC | 16 | $255 |
| GlaxoSmithKline, LLC. | 13 | $220 |
Products named: Auvelity, BREZTRI, VRAYLAR, Kerendia, NUZYRA, OTEZLA, CAPLYTA, TRELEGY ELLIPTA.
Industry payments across LA — which companies pay providers there.
